News

The license has resulted from the success of Altor’s collaboration established in 2004 with Howard Hughes Medical Institute and the Partners AIDS Research Center at Massachusetts General Hospital

Approximately 50 subjects with advanced renal cell carcinoma (RCC) will be enrolled in the Phase IIa trial. The study will be conducted at up to 15 sites in

Developed and manufactured by Sinovac, Anflu is said to be the only split influenza vaccine produced without preservatives in China. Sinovac is undertaking the sales and marketing program

Prior to joining Transcend Medical, Mr Brian was vice president of sales and marketing of Xtent, a publicly traded company developing next-generation drug-eluting stent systems. Mr Brian holds

Results from a 24-week Phase III study have demonstrated that saxagliptin, when used in combination with metformin as an initial therapy, produced reductions across all key measures of

According to the study findings, patients who were taking ALO-01 capsules reported significantly more effective pain relief, as measured by mean change in the weekly brief pain inventory

Mr Erickson is a board member, advisor and consultant to several life science companies and venture capital firms. Mr Erickson has extensive experience in the medical products industry

Five out of the first 20 patients who completed at least one cycle of weekly Marqibo treatment achieved a complete response (CR) or CR without full platelet (CRp)

Under the terms of the agreement, Asuragen will develop and supply reagents for Focus Diagnostics in Asuragen’s QSR-compliant manufacturing facility. Armored RNA is a technology jointly invented and